International Journal of Clinical Oncology

, Volume 22, Issue 1, pp 79–79

Erratum to: Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer

  • Noboru Yamamoto
  • Koichi Goto
  • Makoto Nishio
  • Kenichi Chikamori
  • Toyoaki Hida
  • Makoto Maemondo
  • Nobuyuki Katakami
  • Toshiyuki Kozuki
  • Hiroshige Yoshioka
  • Takashi Seto
  • Kosei Tajima
  • Tomohide Tamura
Erratum

DOI: 10.1007/s10147-016-1052-3

Cite this article as:
Yamamoto, N., Goto, K., Nishio, M. et al. Int J Clin Oncol (2017) 22: 79. doi:10.1007/s10147-016-1052-3

Erratum to: Int J Clin Oncol DOI 10.1007/s10147-016-1039-0

In the original publication of the article, Table 4 was published incorrectly. The corrected Table 4 is published with this erratum.
Table 4

Treatment-related adverse events, all grades (≥30 %) and grade ≥3

 

All grades (≥30 %)

Grade ≥3

Rash

85 (82.5)

15 (14.6)

Diarrhea

82 (79.6)

1 (1.0)

Dry skin

82 (79.6)

5 (4.9)

Paronychia

69 (67.0)

1 (1.0)

Stomatitis

65 (63.1)

1 (1.0)

Pruritus

67 (65.0)

3 (2.9)

Decreased appetite

35 (34.0)

2 (1.9)

ALT increased

33 (32.0)

9 (8.7)

ALT alanine aminotransferase

Copyright information

© Japan Society of Clinical Oncology 2016

Authors and Affiliations

  • Noboru Yamamoto
    • 1
  • Koichi Goto
    • 2
  • Makoto Nishio
    • 3
  • Kenichi Chikamori
    • 4
  • Toyoaki Hida
    • 5
  • Makoto Maemondo
    • 6
  • Nobuyuki Katakami
    • 7
  • Toshiyuki Kozuki
    • 8
  • Hiroshige Yoshioka
    • 9
  • Takashi Seto
    • 10
  • Kosei Tajima
    • 11
  • Tomohide Tamura
    • 12
  1. 1.Department of Thoracic OncologyNational Cancer Centre HospitalTokyoJapan
  2. 2.Department of Thoracic OncologyNational Cancer Centre Hospital EastKashiwaJapan
  3. 3.Thoracic Oncology CentreThe Cancer Institute Hospital of the Japanese Foundation for Cancer ResearchTokyoJapan
  4. 4.Oncology MedicineNational Hospital Organization, Yamaguchi-Ube Medical CentreUbeJapan
  5. 5.Department of Thoracic OncologyAichi Cancer Centre HospitalNagoyaJapan
  6. 6.Department of Respiratory MedicineMiyagi Cancer CentreNatoriJapan
  7. 7.Integrated OncologyInstitute of Biomedical Research and Innovation HospitalKobeJapan
  8. 8.Department of Thoracic OncologyNational Hospital Organization, Shikoku Cancer CentreMatsuyamaJapan
  9. 9.Department of Respiratory MedicineKurashiki Central HospitalKurashikiJapan
  10. 10.Department of Thoracic OncologyNational Kyushu Cancer CentreFukuokaJapan
  11. 11.Clinical Research Planning DepartmentChugai Pharmaceutical Co. LtdTokyoJapan
  12. 12.Thoracic CenterSt Luke’s International HospitalTokyoJapan

Personalised recommendations